FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090768909> ?p ?o ?g. }

• W2090768909 endingPage "123" @default.
• W2090768909 startingPage "123" @default.
• W2090768909 abstract "The pathogenesis of psoriasis is unknown, although it is generally accepted that this chronic inflammatory skin disorder is a complex autoimmune condition similar to other T-cell mediated disorders. Psoriasis imposes a heavy burden on the lifestyle of those affected due to the psychological, arthritic, and cutaneous morbidities; thus significant research has focused on the genetic and immunologic features of psoriasis in anticipation of more targeted, efficacious, and safe therapies. Recently, CD4(+) T helper (Th) 17 cells and interleukins (IL)-12 and -23 have been important in the pathogenesis of T-cell mediated disorders such as psoriasis and has influenced the development of medications that specifically target these key immunological players. Ustekinumab is a monoclonal antibody belonging to a newly developed class of biological, anti-cytokine medications that notably targets the p40 subunit of both IL-12 and -23, both naturally occurring proteins that are important in regulating the immune system and are understood to play a role in immune-mediated inflammatory disorders. Ustekinumab's safety and efficacy has been evaluated for the treatment of moderate-to-severe plaque psoriasis in 3 phase III clinical trials, 2 placebo-controlled (PHOENIX 1 and 2), and 1 comparator-controlled (ACCEPT) study which proved advantageous in patients who were treatment-naive, previously failed other immunosuppressive medications including cyclosporine or methotrexate, were unresponsive to phototherapy, or were unable to use or tolerate other therapies. Ustekinumab has also been investigated for other indications such as psoriatic arthritis, Crohn's disease, and relapsing/remitting multiple sclerosis. We present a concise review evaluating the evidence that supports the use of ustekinumab in the treatment of plaque psoriasis and other conditions." @default.
• W2090768909 created "2016-06-24" @default.
• W2090768909 creator A5038505651 @default.
• W2090768909 creator A5055774579 @default.
• W2090768909 creator A5070814943 @default.
• W2090768909 date "2010-03-01" @default.
• W2090768909 modified "2023-10-03" @default.
• W2090768909 title "Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis" @default.
• W2090768909 cites W1637051416 @default.
• W2090768909 cites W1898779455 @default.
• W2090768909 cites W1909667061 @default.
• W2090768909 cites W1966433665 @default.
• W2090768909 cites W1972194503 @default.
• W2090768909 cites W1976591271 @default.
• W2090768909 cites W1979058179 @default.
• W2090768909 cites W1979349547 @default.
• W2090768909 cites W1983034511 @default.
• W2090768909 cites W2000851235 @default.
• W2090768909 cites W2002124107 @default.
• W2090768909 cites W2002987322 @default.
• W2090768909 cites W2005359518 @default.
• W2090768909 cites W2005553679 @default.
• W2090768909 cites W2006530491 @default.
• W2090768909 cites W2006673542 @default.
• W2090768909 cites W2009495078 @default.
• W2090768909 cites W2012077729 @default.
• W2090768909 cites W2013488106 @default.
• W2090768909 cites W2017987372 @default.
• W2090768909 cites W2018995171 @default.
• W2090768909 cites W2035031252 @default.
• W2090768909 cites W2045113343 @default.
• W2090768909 cites W2054023194 @default.
• W2090768909 cites W2055637177 @default.
• W2090768909 cites W2062557180 @default.
• W2090768909 cites W2066609936 @default.
• W2090768909 cites W2070841284 @default.
• W2090768909 cites W2071343804 @default.
• W2090768909 cites W2075090387 @default.
• W2090768909 cites W2078351936 @default.
• W2090768909 cites W2079267030 @default.
• W2090768909 cites W2081296051 @default.
• W2090768909 cites W2087905758 @default.
• W2090768909 cites W2089241235 @default.
• W2090768909 cites W2105390368 @default.
• W2090768909 cites W2105808377 @default.
• W2090768909 cites W2107066107 @default.
• W2090768909 cites W2107235439 @default.
• W2090768909 cites W2110033222 @default.
• W2090768909 cites W2110888991 @default.
• W2090768909 cites W2115779634 @default.
• W2090768909 cites W2116956799 @default.
• W2090768909 cites W2122723986 @default.
• W2090768909 cites W2123228619 @default.
• W2090768909 cites W2125573161 @default.
• W2090768909 cites W2126162679 @default.
• W2090768909 cites W2132682137 @default.
• W2090768909 cites W2132810497 @default.
• W2090768909 cites W2133657961 @default.
• W2090768909 cites W2134756173 @default.
• W2090768909 cites W2135254713 @default.
• W2090768909 cites W2141045409 @default.
• W2090768909 cites W2151566115 @default.
• W2090768909 cites W2153331620 @default.
• W2090768909 cites W2154218327 @default.
• W2090768909 cites W2158002180 @default.
• W2090768909 cites W2160242026 @default.
• W2090768909 cites W2166356293 @default.
• W2090768909 cites W2167155449 @default.
• W2090768909 cites W2168505126 @default.
• W2090768909 cites W2171541320 @default.
• W2090768909 cites W2329293925 @default.
• W2090768909 cites W2409575143 @default.
• W2090768909 cites W2886978647 @default.
• W2090768909 doi "https://doi.org/10.2147/tcrm.s5599" @default.
• W2090768909 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2857612" @default.
• W2090768909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20421912" @default.
• W2090768909 hasPublicationYear "2010" @default.
• W2090768909 type Work @default.
• W2090768909 sameAs 2090768909 @default.
• W2090768909 citedByCount "22" @default.
• W2090768909 countsByYear W20907689092012 @default.
• W2090768909 countsByYear W20907689092013 @default.
• W2090768909 countsByYear W20907689092014 @default.
• W2090768909 countsByYear W20907689092016 @default.
• W2090768909 countsByYear W20907689092017 @default.
• W2090768909 countsByYear W20907689092019 @default.
• W2090768909 countsByYear W20907689092020 @default.
• W2090768909 countsByYear W20907689092021 @default.
• W2090768909 countsByYear W20907689092022 @default.
• W2090768909 countsByYear W20907689092023 @default.
• W2090768909 crossrefType "journal-article" @default.
• W2090768909 hasAuthorship W2090768909A5038505651 @default.
• W2090768909 hasAuthorship W2090768909A5055774579 @default.
• W2090768909 hasAuthorship W2090768909A5070814943 @default.
• W2090768909 hasBestOaLocation W20907689091 @default.
• W2090768909 hasConcept C156730664 @default.
• W2090768909 hasConcept C17991360 @default.
• W2090768909 hasConcept C203014093 @default.

• next